Cardiac Monitoring & Rhythm Management Devices Market Report 2026-2031, By Type, Application, and Geo

DESCRIPTION
TABLE OF CONTENTS
METHODOLOGY
DOWNLOAD PDF

Cardiac Monitoring & Rhythm Management Devices Market by Type [Cardiac Monitoring (ECG, Ambulatory Monitors), Cardiac Rhythm Management [Pacemaker (Single, Leadless), Defibrillator (AED)], Application [Arrhythmia], End User [Hospital] - Global Forecast to 2031

$27.90B

MARKET SIZE, 2026

$37.88B

MARKET SIZE, 2031

6.3%

CAGR (2026-2031)

2026-2031

FORECAST PERIOD

OVERVIEW

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

The global cardiac monitoring and cardiac rhythm management devices market, valued at USD 26.33 billion in 2025, stood at USD 27.90 billion in 2026 and is projected to advance at a resilient CAGR of 6.3% from 2026 to 2031, culminating in a forecasted valuation of USD 37.88 billion by the end of the period. The rising incidence of cardiovascular diseases and arrhythmias, driven by aging and lifestyle risk factors such as obesity and diabetes, is leading to significant expansion of the cardiac monitoring and rhythm management device market. The market is further driven by innovations in minimally invasive and remote monitoring technologies, growing focus on home healthcare and telemedicine, and increased awareness and early detection of cardiac conditions. Additional factors supporting steady growth include favorable reimbursement policies in developed regions and greater access to cardiac care in emerging markets.

KEY TAKEAWAYS

MARKET SNAPSHOT:
Base Year Market Size (2025): USD 26.33 Billion
Current Market Size (2026): USD 27.90 Billion
Forecast Market Size (2031): USD 37.88 Billion
CAGR (2026�2031): 6.3%
SEGMENT LEADERSHIP:
Regional Trend: Asia Pacific was the fastest regional market.
By Type (Cardiac Monitoring): Non-invasive cardiac monitoring devices accounted for the largest share of 83.9%.
By Type (Cardiac Rhythm Management): Pacemakers accounted for the largest share of 45.8%.
By Application: Arrhythmia accounted for the largest share of 64.7% in 2025.
By End User: Home care settings are projected to register the highest CAGR during the forecast period.
MARKET OUTLOOK & COMPETITIVE LANDSCAPE:
GE HealthCare, Koninklijke Philips N.V., Boston Scientific Corporation, and Baxter are identified as star players in the market due to their broad product portfolios, large-scale manufacturing, strong R&D, and global distribution.
Biotronik, Bittium, and Edan Instruments, Inc. are identified as high-growth innovators/SMEs, carving out niches through regional specialization, novel technologies, and growing presence in emerging markets.

The cardiac monitoring and cardiac rhythm management devices market is growing overall due to the rising prevalence of cardiovascular diseases and arrhythmias, driven largely by an aging global population and increasing lifestyle-related risk factors such as obesity and diabetes. Growth is further supported by technological advancements in minimally invasive and remote monitoring devices, expanding adoption of home healthcare and telemedicine, and improved awareness and early diagnosis of cardiac conditions.

TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS

The cardiac monitoring and rhythm management landscape is rapidly evolving as hospitals, cardiac centers, primary care facilities, ambulatory surgical centers, and home care settings face a rising cardiovascular disease burden and growing demand for continuous, remote, and early-detection solutions. These shifts are pushing providers to adopt advanced, connected, and patient-centric monitoring technologies. As a result, patients increasingly expect faster diagnosis, uninterrupted monitoring, personalized therapy, and improved long-term cardiac outcomes.

Cardiac Monitoring & Rhythm Management Devices Market Disruptions

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

MARKET DYNAMICS

Drivers

Impact
Level

§Increasing incidence of lifestyle and cardiovascular diseases
§Development of wireless monitoring and wearable cardiac devices

RESTRAINTS

Impact
Level

§High costs of cardiac monitoring and rhythm management devices

OPPORTUNITIES

Impact
Level

§Untapped growth potential in emerging markets
§Expanding access to advanced cardiac diagnostics with AI and CMS support

CHALLENGES

Impact
Level

§Frequent product recalls

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: GROWTH, SIZE, SHARE, AND TRENDS: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY	USE CASE DESCRIPTION	BENEFITS
	Implantable cardiac rhythm management devices (pacemakers, ICDs, CRT), remote cardiac monitoring systems	Improved arrhythmia management, reduced sudden cardiac death risk, advanced remote patient monitoring
	Pacemakers, implantable loop recorders, cardiac monitors, and CRM systems	Long device longevity, continuous rhythm monitoring, enhanced diagnostic accuracy
	Pacemakers, ICDs, CRT devices, wearable and implantable cardiac monitors	Reliable rhythm control, improved heart failure outcomes, strong physician adoption
	Ambulatory ECG monitoring, cardiac telemetry, patient monitoring systems	Continuous cardiac surveillance, early arrhythmia detection, integrated hospital workflows
	Holter monitors, ECG systems, cardiac telemetry and patient monitoring platforms	High-quality signal acquisition, scalable monitoring solutions, broad hospital adoption

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET ECOSYSTEM

The trend in the cardiac monitoring and rhythm management devices market is toward an integrated ecosystem in which device manufacturers produce ECG monitors, Holter systems, implantable recorders, pacemakers, and defibrillators, supported by component suppliers, contract manufacturers, and OEM partners. The devices must comply with safety, performance, and cybersecurity standards set by regulatory authorities. These include the remarkable things created by digital health innovators such as Al-driven analytics, cloud connectivity, and remote monitoring. It all gets to the hospitals, cardiac centers, ahome care settings through distributors and logistics partners, with clinicians and biomedical teams now at the end of the chain,ain throwing the major adoption impetus. There are, however, new and continued trends such as miniaturization, wireless technologies, advanced arrhythmia detection, and digitally integrated care pathways that increasingly shape the ecosystem.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

MARKET SEGMENTS

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

CARDIAC MONITORING DEVICES MARKET, BY TYPE

Non-invasive cardiac monitoring devices hold a large market share because of their ease of use, patient comfort, and lower procedural risk compared with implantable solutions. They enable continuous or intermittent monitoring without surgery, making them suitable for a broad patient population across hospitals, clinics, and homecare settings. Lower costs, faster deployment, minimal regulatory and reimbursement barriers, and growing adoption of wearable and wireless technologies further drive their widespread use. Additionally, rising demand for remote patient monitoring and early arrhythmia detection supports the strong preference for non-invasive solutions.

CARDIAC RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE

Defibrillators hold a large share of the cardiac rhythm management market due to their critical, life-saving role in treating sudden cardiac arrest and life-threatening ventricular arrhythmias. Their widespread adoption across hospitals, emergency medical services, public-access settings, and home care is supported by strong clinical guidelines and government initiatives promoting automated external defibrillator (AED) deployment. Rising cardiovascular disease prevalence, growing awareness of sudden cardiac death, and technological advances, including portable, wearable, and implantable defibrillators, further contribute to their strong market share.

CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION

Arrhythmia is a major segment of the cardiac monitoring and rhythm management market due to its high prevalence, association with serious outcomes such as stroke and sudden cardiac death, and the need for continuous or long-term monitoring. The rising incidence of atrial fibrillation and other rhythm disorders, driven by aging populations and lifestyle-related risk factors, has increased demand for accurate detection and management solutions. Advances in non-invasive monitoring, implantable devices, and AI-enabled rhythm analysis further underscore the importance of arrhythmia diagnosis and treatment.

CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY End user

Hospitals account for a significant share of the cardiac monitoring and rhythm management devices market because they serve as primary centers for diagnosis, acute care, and complex cardiac interventions. They house advanced infrastructure, including intensive care units, electrophysiology labs, and catheterization centers, enabling the use of both non-invasive and implantable devices. High patient volume, availability of skilled cardiologists and electrophysiologists, and access to reimbursement and emergency care services further drive strong adoption of cardiac monitoring and rhythm management technologies in hospital settings.

REGION

Asia Pacific to be fastest-growing region in global cardiac monitoring and rhythm management devices market during forecast period

The Asia Pacific region is expected to post the highest growth rate in the cardiac monitoring and rhythm management devices market, driven by a rapidly expanding elderly population and rising prevalence of cardiovascular diseases. Improving healthcare infrastructure, greater access to advanced cardiac care, and growing government and private-sector investments are accelerating adoption. Additionally, expanding medical tourism, rising awareness of early diagnosis, and the entry of cost-effective devices and local manufacturers further support strong market growth across the region.

Cardiac Monitoring & Rhythm Management Devices Market Region

CARDIAC MONITORING & CARDIAC RHYTHM MANAGEMENT DEVICES MARKET: GROWTH, SIZE, SHARE, AND TRENDS: COMPANY EVALUATION MATRIX

In the cardiac monitoring and rhythm management devices market matrix, GE Healthcare (Star) leads globally with a broad portfolio, a strong international presence, and advanced digital cardiac monitoring technologies that drive widespread adoption across care settings. OSI Systems Inc. (Emerging Leader) is expanding through specialized, cost-effective solutions focused on niche applications, emerging markets, and ambulatory and home-based cardiac care.

Cardiac Monitoring & Rhythm Management Devices Market Evaluation Metrics

Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis

KEY MARKET PLAYERS

GE HealthCare (US)
Koninklijke Philips N.V. (Netherlands)
Boston Scientific Corporation (US)
Baxter (US)
Medtronic (Ireland)
Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China)
Abbott (US)
Stryker (US)
NIHON KOHDEN CORPORATION (Japan)
MicroPort Scientific Corporation (China)
FUKUDA DENSHI (Japan)
OSI Systems, Inc. (US)
iRhythm Inc. (US)
Lepu Medical Technology (Beijing) Co., Ltd. (China)
AliveCor, Inc. (US)

MARKET SCOPE

REPORT METRIC	DETAILS
Market Size Value in 2025	USD 26.33 Billion
Revenue Forecast in 2031	USD 37.88 Billion
Growth Rate	CAGR of 6.3% from 2026-2031
Years Considered	2024-2031
Base year	2025
Forecast period	2026–2031
Units considered	Value (USD million/billion)
Report Coverage	Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments Covered	Cardiac Monitoring devices by Type: NON-INVASIVE CARDIAC MONITORING DEVICES INVASIVE CARDIAC MONITORING DEVICES Cardiac Rhythnm Management devices by type: Pacemakers defibrillators Cardiac Resynchronization Therapy . By Application: Arrhythmias myocardial infarction heart failure other applications By End User: hospitals primary care centers cardiac centers ambulatory surgical centers home care setting other end users
Regions Covered	North America, Asia Pacific, Europe, Latin America, Middle East & Africa

DELIVERED CUSTOMIZATIONS

We have successfully delivered the following deep-dive customizations:

CLIENT REQUEST	CUSTOMIZATION DELIVERED	VALUE ADDS
Product Analysis	In-depth assessment of cardiac monitoring and rhythm management devices by product type (ECG machines, Holter monitors, event monitors, mobile cardiac telemetry, implantable loop recorders, pacemakers, implantable cardioverter defibrillators [ICDs], cardiac resynchronization therapy [CRT] devices), technology (wired, wireless, wearable, implantable), and end user (hospitals, cardiology clinics, ambulatory centers, home monitoring).	Analysis of emerging trends such as AI-enabled arrhythmia detection, wearable and patch-based monitors, remote patient monitoring (RPM), cloud-based data analytics, miniaturized implantable devices, and extended battery-life technologies improving early diagnosis and long-term disease management.
Company Information	Comprehensive profiles of leading global players such as Medtronic, Abbott, Boston Scientific, Philips, GE HealthCare, Biotronik, and other regional and emerging manufacturers.	Identification of strategic partnerships, digital health collaborations, regulatory approvals, product launches, pipeline developments, and mergers & acquisitions shaping innovation and competition in the cardiac monitoring and rhythm management landscape.
Geographic Analysis	Region- and country-level demand mapping across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa; evaluation of regulatory pathways, reimbursement policies, healthcare infrastructure, and technology adoption rates.	Regional market outlook highlighting growth opportunities driven by rising cardiovascular disease prevalence, aging populations, increasing adoption of remote cardiac monitoring, expansion of home-based care models, and favorable reimbursement frameworks for digital and implantable cardiac devices.

RECENT DEVELOPMENTS

October 2025 : Abbott launched AVEIR DR Dual-Chamber Leadless Pacemaker System in India, the world’s first dual-chamber leadless pacemaker that enables wireless, beat-by-beat synchronisation between two miniaturised devices without traditional leads or a chest pocket. The system is intended to reduce complications associated with lead-based pacemakers and extend leadless pacing options to a broader patient cohort in India needing dual-chamber support.
January 2025 : Sutter Health and GE Healthcare entered a seven-year Care Alliance partnership to expand access to AI-powered imaging across California, improving patient care and clinician efficiency. The partnership includes upgrading technology like PET/CT, MRI, and ultrasound across Sutter’s facilities and supports new care sites and specialty centers.
June 2024 : Philips launched the Cardiac Workstation in EMEA to transform diagnostic cardiology by using advanced algorithms that streamline ECG data collection and analysis. The platform helps clinicians prioritize at-risk patients and reduces administrative burdens, enabling faster, more efficient care.
September 2024 : Boston Scientific received U.S. Food & Drug Administration (FDA) approval to expand the indication for its INGEVITY™+ Pacing Leads to include conduction-system pacing (CSP) and sensing of the left bundle branch area (LBBA) when connected to single- or dual-chamber pacemakers. This expanded indication supports an alternative pacing strategy aimed at enhancing ventricular synchrony and potentially reducing the long-term risk of heart failure compared to traditional right-ventricular pacing

checkmark Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.

TITLE

PAGE NO

INTRODUCTION

EXECUTIVE SUMMARY

PREMIUM INSIGHTS

MARKET OVERVIEW

Emerging markets and innovative devices drive growth amidst regulatory and cost challenges in cardiac care.

4.1

INTRODUCTION

4.2

MARKET DYNAMICS

4.2.1

DRIVERS

4.2.1.1

RISING GERIATRIC POPULATION WITH CHRONIC CARDIOVASCULAR DISEASES

4.2.1.2

INCREASING INCIDENCE OF LIFESTYLE AND CARDIOVASCULAR DISEASES

4.2.1.3

DEVELOPMENT OF WIRELESS MONITORING AND WEARABLE CARDIAC DEVICES

4.2.1.4

RAPID ADOPTION OF LEADLESS PACEMAKERS

4.2.1.5

INCREASING FOCUS ON PROVIDING PUBLIC-ACCESS DEFIBRILLATORS

4.2.2

RESTRAINTS

4.2.2.1

INCREASING REGULATORY SCRUTINY EXTENDING TIME-TO-MARKET FOR CARDIAC DEVICES

4.2.2.2

HIGH DEVICE COSTS AND REIMBURSEMENT GAPS

4.2.3

OPPORTUNITIES

4.2.3.1

UNTAPPED GROWTH POTENTIAL IN EMERGING MARKETS

4.2.3.2

EMERGENCE OF LEADLESS CRT PLATFORMS

4.2.4

CHALLENGES

4.2.4.1

FREQUENT PRODUCT RECALLS

4.3

UNMET NEEDS & WHITE SPACES

4.3.1

UNMET NEEDS

4.3.2

WHITE SPACE OPPORTUNITIES

4.4

INTERCONNECTED MARKETS & CROSS-SECTOR OPPORTUNITIES

4.4.1

INTERCONNECTED MARKETS

4.4.2

CROSS-SECTOR OPPORTUNITIES

4.5

STRATEGIC MOVES BY TIER-1/2/3 PLAYERS

4.5.1

KEY STRATEGIC MOVES BY TIER-1/2/3 PLAYERS IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET

INDUSTRY TRENDS

Navigate industry dynamics to capitalize on emerging trends in cardiac device pricing and supply chain strategies.

5.1

PORTER’S FIVE FORCES ANALYSIS

5.1.1

THREAT OF NEW ENTRANTS

5.1.2

THREAT OF SUBSTITUTES

5.1.3

BARGAINING POWER OF BUYERS

5.1.4

BARGAINING POWER OF SUPPLIERS

5.1.5

INTENSITY OF COMPETITIVE RIVALRY

5.2

MACROECONOMICS OUTLOOK

5.2.1

GDP TRENDS AND FORECAST

5.2.2

TRENDS IN GLOBAL HEALTHCARE INDUSTRY

5.2.3

TRENDS IN GLOBAL MEDICAL DEVICE INDUSTRY

5.3

SUPPLY CHAIN ANALYSIS

5.4

VALUE CHAIN ANALYSIS

5.5

ECOSYSTEM ANALYSIS

5.5.1

ROLE IN ECOSYSTEM

5.6

PRICING ANALYSIS

5.6.1

AVERAGE SELLING PRICE TREND OF CARDIAC MONITORING DEVICES, BY KEY PLAYER, 2024 AND 2025 (USD)

5.6.1.1

AVERAGE SELLING PRICE OF HOLTER MONITORS, BY KEY PLAYER, 2025

5.6.1.2

AVERAGE SELLING PRICE OF EXTERNAL DEFIBRILLATORS, BY KEY PLAYER, 2024

5.6.2

AVERAGE SELLING PRICE TREND OF CARDIAC RHYTHM MANAGEMENT DEVICES, BY REGION, 2023–2025

5.7

TRADE ANALYSIS

5.7.1

IMPORT DATA FOR HS CODE 901811, 2021–2024

5.7.2

EXPORT DATA FOR HS CODE 901811, 2021–2024

5.8

KEY CONFERENCES & EVENTS, 2025–2026

5.9

TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS

5.10

INVESTMENT & FUNDING SCENARIO

5.11

CASE STUDY ANALYSIS

5.11.1

DUAL-CHAMBER LEADLESS PACEMAKER BY ABBOTT

5.11.2

CARDIOSOFT ECG-BICESTER HEALTH CENTRE IN NUMED HEALTHCARE

5.11.3

POST-STROKE ATRIAL FIBRILLATION DETECTION WITH PHILIPS BIOTEL HEART MCOT

5.12

IMPACT OF 2025 US TARIFF ON CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET

5.12.1

KEY TARIFF RATES

5.12.2

PRICE IMPACT ANALYSIS

5.12.3

IMPACT ON COUNTRY/REGION

5.12.4

IMPACT ON END-USE INDUSTRIES

DSTRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTIONS

Harness AI and emerging tech for disruptive advancements in cardiac diagnostics and rhythm management.

6.1

TECHNOLOGY ANALYSIS

6.1.1

KEY EMERGING TECHNOLOGIES

6.1.1.1

ARTIFICIAL INTELLIGENCE (AI) AND PREDICTIVE ANALYTICS

6.1.1.2

MINIATURIZATION OF CARDIAC DEVICES

6.1.2

COMPLEMENTARY TECHNOLOGIES

6.1.2.1

WEARABLE BIOSENSORS

6.1.3

ADJACENT TECHNOLOGIES

6.1.3.1

VITAL SIGN MONITORS

6.2

TECHNOLOGY/PRODUCT ROADMAP

6.2.1

NEAR TERM (2025–2027)

6.2.2

MID TERM (2028–2030)

6.2.3

LONG TERM (2030+)

6.3

PATENT ANALYSIS

6.3.1

JURISDICTION AND TOP APPLICANT ANALYSIS

6.4

FUTURE APPLICATIONS

6.4.1

FULLY AUTONOMOUS CARDIAC DIAGNOSTICS & DECISION-SUPPORT ECOSYSTEMS

6.4.2

PRECISION RHYTHM MANAGEMENT THROUGH PREDICTIVE & PRE-EMPTIVE THERAPY DELIVERY

6.4.3

FULLY LEADLESS, MODULAR, AND WIRELESSLY NETWORKED CARDIAC SYSTEMS

6.4.4

REGENERATIVE-INTEGRATED RHYTHM MANAGEMENT SYSTEMS

6.5

IMPACT OF AI/GEN AI ON CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET

6.5.1

MARKET POTENTIAL OF AI

6.5.2

AI USE CASES

6.5.3

KEY COMPANIES IMPLEMENTING AI

6.5.4

BEST PRACTICES IN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES

6.5.5

CASE STUDIES OF AI IMPLEMENTATION

6.5.6

INTERCONNECTED ADJACENT ECOSYSTEM AND IMPACT ON MARKET PLAYERS

6.5.7

CLIENTS’ READINESS TO ADOPT GENERATIVE AI

SUSTAINABILITY AND REGULATORY LANDSCAPE

Navigate global sustainability regulations and eco-standards to leverage recyclable biomaterials in ECG patches.

103

7.1

REGULATORY LANDSCAPE

7.1.1

REGULATORY FRAMEWORK

7.1.1.1

NORTH AMERICA

7.1.1.2

EUROPE

7.1.1.3

ASIA PACIFIC

7.1.1.4

LATIN AMERICA

7.1.1.5

MIDDLE EAST & AFRICA

7.1.2

REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS

7.1.3

INDUSTRY STANDARDS

7.2

SUSTAINABILITY INITIATIVES

7.2.1

RECYCLABLE BIOMATERIALS FOR ECG PATCHES

7.2.2

SUSTAINABILITY IMPACT AND REGULATORY POLICY INITIATIVES

7.2.3

CERTIFICATIONS, LABELING, AND ECO-STANDARDS

CUSTOMER LANDSCAPE & BUYER BEHAVIOR

Understand key stakeholders and criteria driving cardiac device purchases amidst unmet industry needs.

110

8.1

KEY STAKEHOLDERS & BUYING CRITERIA

8.1.1

KEY STAKEHOLDERS IN BUYING PROCESS

8.1.2

BUYING CRITERIA

8.2

CUSTOMER LANDSCAPE & BUYER BEHAVIOR

8.2.1

DECISION-MAKING PROCESS

8.2.2

ADOPTION BARRIERS & INTERNAL CHALLENGES

8.2.3

UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES

8.2.4

MARKET PROFITABILITY

RHYTHM MANAGEMENT DEVICES MARKET, BY TYPE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 23 Data Tables

115

9.1

INTRODUCTION

9.2

PACEMAKERS

9.2.1

SINGLE-CHAMBER PACEMAKERS

9.2.1.1

INCREASING USE OF SINGLE-CHAMBER PACEMAKERS FOR MANAGING BRADYARRHYTHMIAS AND CONDUCTION DISORDERS TO AID MARKET GROWTH

9.2.2

DUAL-CHAMBER PACEMAKERS

9.2.2.1

DUAL-CHAMBER PACEMAKERS TO WITNESS HIGH DEMAND WITH WIDESPREAD USAGE

9.2.3

LEADLESS CHAMBER PACEMAKERS

9.2.3.1

FOCUS ON MINIMALLY INVASIVE IMPLANTATION AND REDUCED COMPLICATION RATES TO PROPEL MARKET GROWTH

9.3

DEFIBRILLATORS

9.3.1

IMPLANTABLE CARDIOVERTER DEFIBRILLATORS (ICDS)

9.3.1.1

SINGLE-CHAMBER IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICDS)

9.3.1.1.1

UTILIZATION IN ARTERIAL MONITORING TO SUPPORT MARKET GROWTH

9.3.1.2

DUAL-CHAMBER IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICDS)

9.3.1.2.1

ABILITY TO REDUCE INCIDENCE OF INAPPROPRIATE SHOCKS TO DRIVE MARKET

9.3.1.3

SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (ICDS)

9.3.1.3.1

BENEFITS OF ELIMINATING CARDIAC LEADS TO DRIVE MARKET

9.3.2

EXTERNAL DEFIBRILLATORS

9.3.2.1

AUTOMATED EXTERNAL DEFIBRILLATORS (AEDS)

9.3.2.1.1

SMART AUTOMATED EXTERNAL DEFIBRILLATORS ADVANCING PUBLIC CARDIAC EMERGENCY RESPONSE TO AID MARKET GROWTH

9.3.2.2

MANUAL EXTERNAL DEFIBRILLATORS

9.3.2.2.1

INNOVATION IN MANUAL EXTERNAL DEFIBRILLATORS TO ENHANCE EMERGENCY CARDIAC CARE

9.3.2.3

WEARABLE CARDIOVERTER DEFIBRILLATORS (WCDS)

9.3.2.3.1

OPERATIONAL DIFFICULTIES AND FALSE ALARMS TO RESTRAIN MARKET ADOPTION

9.4

CARDIAC RESYNCHRONIZATION THERAPY (CRT)

9.4.1

CARDIAC RESYNCHRONIZATION THERAPY-PACEMAKERS (CRT-P)

9.4.2

CARDIAC RESYNCHRONIZATION THERAPY-DEFIBRILLATORS (CRT-D)

CARDIAC MONITORING DEVICES MARKET, BY TYPE

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million and Units | 15 Data Tables

147

10.1

INTRODUCTION

10.2

NON-INVASIVE CARDIAC MONITORING DEVICES

10.2.1

ELECTROCARDIOGRAM (ECG/EKG) MONITORS

10.2.1.1

STANDARD 12-LEAD ECG MACHINES (RESTING ECG MONITORS)

10.2.1.1.1

WIDE AVAILABILITY OF RESTING ECG DEVICES TO SUPPORT MARKET GROWTH

10.2.1.2

STRESS ECG SYSTEMS

10.2.1.2.1

HIGH COST OF STRESS ECG DEVICES TO LIMIT ADOPTION

10.2.1.3

HANDHELD/SMART ECG MONITORS

10.2.1.3.1

RISING ADOPTION OF AI TECHNOLOGY AND GROWING NEED TO MINIMIZE TREATMENT COSTS TO SUPPORT MARKET GROWTH

10.2.2

AMBULATORY CARDIAC MONITORS

10.2.2.1

HOLTER MONITORS

10.2.2.1.1

GROWING DEMAND FOR CONTINUOUS MONITORING TO FUEL SEGMENT GROWTH

10.2.2.2

EVENT MONITORS

10.2.2.2.1

INCREASING OUTSOURCING OF MONITORING DEVICES TO PROPEL MARKET GROWTH

10.2.2.3

MOBILE CARDIAC TELEMETRY (MCT) DEVICES

10.2.2.3.1

INCREASING DEMAND FOR CARDIAC MONITORING SOLUTIONS IN HOME CARE SETTINGS TO AID SEGMENT GROWTH

10.2.2.4

LONG-TERM CONTINUOUS ECG MONITORS

10.2.2.4.1

INCREASING ADOPTION OF PATCH-BASED ECG MONITORS FOR EXTENDED AMBULATORY CARDIAC MONITORING TO AID MARKET GROWTH

10.3

INVASIVE CARDIAC MONITORING DEVICES

10.3.1

INTRODUCTION OF TECHNOLOGICALLY ADVANCED IMPLANTABLE LOOP RECORDERS TO SUPPORT MARKET GROWTH

CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY APPLICATION

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 5 Data Tables

169

11.1

INTRODUCTION

11.2

ARRHYTHMIAS

11.2.1

GROWING NUMBER OF ATRIAL FIBRILLATION CASES TO DRIVE MARKET

11.3

HEART FAILURE

11.3.1

GROWING PREVALENCE OF CHRONIC LIFESTYLE DISEASES TO DRIVE PREVALENCE OF HEART FAILURE

11.4

MYOCARDIAL INFARCTION (MI)

11.4.1

RISING GERIATRIC POPULATION TO SPUR MARKET GROWTH

11.5

OTHER APPLICATIONS

CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY END USER

Market Size & Growth Rate Forecast Analysis to 2031 in USD Million | 7 Data Tables

177

12.1

INTRODUCTION

12.2

HOSPITALS

12.2.1

INCREASING UTILIZATION OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES IN HOSPITALS TO AID MARKET GROWTH

12.3

PRIMARY CARE CENTERS

12.3.1

WIDENING ACCESS TO ECG MONITORING IN PRIMARY CARE CENTERS TO BOOST MARKET PENETRATION

12.4

CARDIAC CENTERS

12.4.1

INCREASED INCIDENCE OF CARDIOVASCULAR DISEASE AND HIGH DEMAND FOR SPECIALIZED CARE TO BOOST MARKET GROWTH

12.5

AMBULATORY SURGICAL CENTERS

12.5.1

GROWING NEED FOR PRE-OPERATIVE CARDIAC SCREENING IN AMBULATORY SURGICAL CENTERS TO INFLUENCE MARKET DEMAND

12.6

HOME CARE SETTINGS

12.6.1

RISING PREFERENCE FOR REMOTE CARDIAC MONITORING TO FUEL MARKET GROWTH

12.7

OTHER END USERS

CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET, BY REGION

Comprehensive coverage of 8 Regions with country-level deep-dive of 19 Countries | 379 Data Tables.

189

13.1

INTRODUCTION

13.2

NORTH AMERICA

13.2.1

MACROECONOMIC OUTLOOK FOR NORTH AMERICA

13.2.2

13.2.2.1

US TO DOMINATE NORTH AMERICAN CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES MARKET DURING FORECAST PERIOD

13.2.3

CANADA

13.2.3.1

HIGH BURDEN OF CARDIOVASCULAR DISEASES TO SUPPORT MARKET GROWTH

13.3

EUROPE

13.3.1

MACROECONOMIC OUTLOOK FOR EUROPE

13.3.2

GERMANY

13.3.2.1

HIGH HEALTHCARE SPENDING TO PROPEL MARKET GROWTH

13.3.3

FRANCE

13.3.3.1

FAVORABLE GOVERNMENT INITIATIVES TO SUPPORT MARKET GROWTH

13.3.4

13.3.4.1

RISING DEMAND FOR HOME-BASED SMART ECG DEVICES TO SUPPORT MARKET GROWTH

13.3.5

ITALY

13.3.5.1

GROWING FOCUS ON IMPROVEMENTS IN PATIENT CARE TO DRIVE MARKET

13.3.6

SPAIN

13.3.6.1

RISING GERIATRIC POPULATION TO SUPPORT MARKET GROWTH IN SPAIN

13.3.7

AUSTRIA

13.3.7.1

FAVOURABLE INSURANCE COVERAGE FOR CARDIAC DIAGNOSTIC PROCEDURES TO SUPPORT MARKET GROWTH

13.3.8

NETHERLANDS

13.3.8.1

STRONG PRIMARY CARE REFERRAL PATHWAY TO AID ADOPTION OF CARDIAC MONITORING AND RHYTHM DEVICES

13.3.9

SWEDEN

13.3.9.1

EXPANSION OF LONG-TERM AMBULATORY ECG MONITORING TO AUGMENT MARKET GROWTH

13.3.10

REST OF EUROPE

13.4

ASIA PACIFIC

13.4.1

MACROECONOMIC OUTLOOK FOR ASIA PACIFIC

13.4.2

JAPAN

13.4.2.1

HIGH HEALTHCARE EXPENDITURE AND FAVORABLE REIMBURSEMENT AND INSURANCE COVERAGE TO SUPPORT MARKET GROWTH

13.4.3

CHINA

13.4.3.1

GOVERNMENT SUPPORT FOR INFRASTRUCTURAL IMPROVEMENT TO DRIVE MARKET

13.4.4

INDIA

13.4.4.1

INCREASING CARDIAC DISEASE BURDEN INTENSIFIES DEMAND FOR CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES

13.4.5

AUSTRALIA

13.4.5.1

AUSTRALIA TO STRENGTHEN COMMUNITY ACCESS TO RHYTHM MANAGEMENT DEVICES THROUGH POLICY AND TARGETED FUNDING

13.4.6

SOUTH KOREA

13.4.6.1

RISING GERIATRIC POPULATION TO PROPEL MARKET GROWTH

13.4.7

REST OF ASIA PACIFIC

13.5

LATIN AMERICA

13.5.1

MACROECONOMIC OUTLOOK FOR LATIN AMERICA

13.5.2

BRAZIL

13.5.2.1

IMPROVING ACCESS TO DIAGNOSTIC SERVICES TO DRIVE MARKET GROWTH

13.5.3

MEXICO

13.5.3.1

RISING INCIDENCES OF HEART DISEASE TO PROPEL MARKET GROWTH

13.5.4

COLOMBIA

13.5.4.1

HIGH ARRHYTHMIA BURDEN TO DRIVE DEMAND FOR CARDIAC RHYTHM MONITORING IN COLOMBIA

13.5.5

REST OF LATIN AMERICA

13.6

MIDDLE EAST & AFRICA

13.6.1

MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA

13.6.2

GCC COUNTRIES

13.6.2.1

KINGDOM OF SAUDI ARABIA

13.6.2.1.1

HIGH PREVALENCE OF CARDIOVASCULAR DISEASES AND INCREASED DEMAND FOR CARDIAC DIAGNOSTIC SOLUTIONS TO DRIVE MARKET

13.6.2.2

UAE

13.6.2.2.1

FOCUS ON NATIONAL CVD SCREENING PROGRAMS AND DIGITAL HEALTH STRATEGIES TO AUGMENT MARKET GROWTH

13.6.2.3

REST OF GCC COUNTRIES

13.6.3

REST OF MIDDLE EAST & AFRICA

COMPETITIVE LANDSCAPE

Discover market dominators and emerging disruptors shaping future competitive dynamics.

360

14.1

INTRODUCTION

14.2

KEY PLAYER STRATEGIES/RIGHT TO WIN

14.2.1

OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS

14.3

REVENUE ANALYSIS, 2022–2024

14.4

MARKET SHARE ANALYSIS, 2025

14.5

BRAND COMPARISON

14.6

COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024

14.6.1

STARS

14.6.2

EMERGING LEADERS

14.6.3

PERVASIVE PLAYERS

14.6.4

PARTICIPANTS

14.6.5

COMPANY PRODUCT FOOTPRINT: KEY PLAYERS, 2024

14.6.5.1

COMPANY FOOTPRINT

14.6.5.2

REGION FOOTPRINT

14.6.5.3

TYPE FOOTPRINT

14.6.5.4

TYPE FOOTPRINT

14.6.5.5

APPLICATION FOOTPRINT

14.7

COMPANY EVALUATION MATRIX FOR STARTUPS/SMES, 2024

14.7.1

PROGRESSIVE COMPANIES

14.7.2

RESPONSIVE COMPANIES

14.7.3

DYNAMIC COMPANIES

14.7.4

STARTING BLOCKS

14.7.5

COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024

14.7.5.1

DETAILED LIST OF KEY STARTUPS/SMES

14.7.5.2

COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES

14.8

COMPANY VALUATION & FINANCIAL METRICS

14.8.1

FINANCIAL METRICS

14.8.2

COMPANY VALUATION

14.9

COMPETITIVE SCENARIO

14.9.1

PRODUCT LAUNCHES & APPROVALS

14.9.2

DEALS

14.9.3

EXPANSIONS

14.9.4

OTHER DEVELOPMENTS

COMPANY PROFILES

In-depth Company Profiles of Leading Market Players with detailed Business Overview, Product and Service Portfolio, Recent Developments, and Unique Analyst Perspective (MnM View)

385

15.1

KEY PLAYERS

15.1.1

GE HEALTHCARE

15.1.1.1

BUSINESS OVERVIEW

15.1.1.2

PRODUCTS OFFERED

15.1.1.3

RECENT DEVELOPMENTS

15.1.1.3.1

DEALS

15.1.1.3.2

OTHER DEVELOPMENTS

15.1.1.4

MNM VIEW

15.1.1.4.1

RIGHT TO WIN

15.1.1.4.2

STRATEGIC CHOICES

15.1.1.4.3

WEAKNESSES & COMPETITIVE THREATS

15.1.2

KONINKLIJKE PHILIPS N.V.

15.1.3

BOSTON SCIENTIFIC CORPORATION

15.1.4

BAXTER (HILL-ROM HOLDINGS, INC.)

15.1.5

MEDTRONIC

15.1.6

SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.

15.1.7

ABBOTT

15.1.8

STRYKER

15.1.9

NIHON KOHDEN CORPORATION

15.1.10

MICROPORT SCIENTIFIC CORPORATION

15.1.11

FUKUDA DENSHI

15.1.12

OSI SYSTEMS, INC.

15.1.13

IRHYTHM INC.

15.1.14

LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD.

15.1.15

ALIVECOR, INC.

15.2

OTHER PLAYERS

15.2.1

SCHILLER

15.2.2

CARDIAC INSIGHT, INC.

15.2.3

BIOTRONIK

15.2.4

BITTIUM

15.2.5

BPL MEDICAL TECHNOLOGIES

15.2.6

LIFESIGNALS

15.2.7

CUMEDICAL

15.2.8

BIOTRICITY

15.2.9

EDAN INSTRUMENTS, INC.

15.2.10

VITALCONNECT

RESEARCH METHODOLOGY

466

16.1

RESEARCH DATA

16.1.1

SECONDARY DATA

16.1.1.1

KEY SECONDARY SOURCES

16.1.1.2

KEY DATA FROM SECONDARY SOURCES

16.1.2

PRIMARY DATA

16.1.2.1

PRIMARY SOURCES

16.1.2.2

KEY OBJECTIVES OF PRIMARY RESEARCH

16.1.2.3

KEY INDUSTRY INSIGHTS

16.1.2.4

BREAKDOWN OF PRIMARIES

16.2

MARKET SIZE ESTIMATION OF CARDIAC MONITORING AND RHYTHM MANAGEMENT DEVICES

16.2.1

REVENUE SHARE ANALYSIS (BOTTOM-UP APPROACH)

16.2.2

MNM REPOSITORY ANALYSIS

16.2.3

COMPANY INVESTORS PRESENTATIONS AND PRIMARY INTERVIEWS

16.2.4

TOP-DOWN APPROACH

16.2.5

BOTTOM-UP APPROACH

16.2.6

PRIMARY INTERVIEWS

16.2.7

DEMAND-SIDE APPROACH

16.3

MARKET GROWTH RATE PROJECTION

16.4

DATA TRIANGULATION

16.4.1

STUDY ASSUMPTIONS

16.4.2

RESEARCH LIMITATIONS

16.5

RISK ANALYSIS

APPENDIX

480

17.1

DISCUSSION GUIDE

17.2

KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL

17.3

CUSTOMIZATION OPTIONS

17.3.1

Methodology

The study involved four major activities in estimating the current size of the cardiac monitoring and cardiac rhythm management devices market. Exhaustive secondary research was conducted to gather information on the market and its subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.

Secondary Research

In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify and collect information for this study.

Primary Research

Extensive primary research was conducted after acquiring knowledge about the global market scenario through secondary research. Primary interviews were conducted from both the demand (cardiologists, Surgeons, Cardiac consultants) and supply sides (cardiac monitoring & cardiac rhythm management devices providers and distributors).

The following is a breakdown of the primary respondents:

Cardiac Monitoring & Rhythm Management Devices Market

Note 1: Others include sales managers, marketing managers, and product managers.

Note 2. Tiers of companies are defined based on their total revenue. As of 2025: Tier 1 = >USD 5 billion, Tier 2 = USD 500 million to USD 5 billion, and Tier 3 = < USD 500 million.

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the cardiac monitoring & cardiac rhythm management devices Market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

The key players in the industry and markets have been identified through extensive secondary research
The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the overall market size through market sizing processes, the market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics of each market segment and subsegment, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by examining various factors and trends on both the demand and supply sides of the cardiac monitoring & cardiac rhythm management devices industry.

Market Definition

Cardiac monitoring is the continuous monitoring of cardiac activity using devices such as electrocardiographs, recording devices, and visual/audible recorders. These devices are used to identify or rule out a cardiac rhythm disorder and determine the appropriate course of treatment. Cardiac rhythm management devices include implantable devices (defibrillators and pacemakers), leads, and external devices used to treat and manage arrhythmia-related diseases. The major end users of implantable pacemakers and defibrillators are hospitals, cardiac centers, clinics, and ambulatory surgery centers.

Stakeholders

Manufacturers of cardiac monitoring devices and rhythm management devices
Distributors of cardiac monitoring devices and rhythm management devices
Hospitals, primary care centers, and cardiac centers
Ambulatory surgical centers
Non-government organizations
Government regulatory authorities
Contract manufacturers & third-party suppliers
Research laboratories & academic institutes
Clinical research organizations (CROs)
Government & non-governmental regulatory authorities
Market research & consulting firms

Report Objectives

To define, describe, segment, and forecast the global cardiac monitoring and cardiac rhythm management devices market, by type, application, end user, and region
To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
To strategically analyze the regulatory scenario, value chain analysis, supply chain analysis, Porter’s Five Forces analysis, ecosystem analysis, trade analysis, pricing analysis, patent analysis, impact of AI, case study analysis, unmet needs/end-user expectations, impact of US tariffs, and trends/disruption impacting customers’ business in the market.
To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
To analyze the opportunities in the market for stakeholders and provide details on the competitive landscape for market leaders
To strategically analyze the cardiac monitoring and cardiac rhythm management devices market in five regions: North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
To track and analyze competitive developments, including acquisitions, product & service launches, partnerships, and expansions, in the cardiac monitoring and cardiac rhythm management (CM & CRM) devices market.
To track and analyze competitive developments such as acquisitions, product launches & enhancements, partnerships, agreements, contracts, & collaborations, and R&D activities in the CM & CRM devices market.

REPORT COVERAGE

＋

REPORT OVERVIEW
KEY TAKEAWAYS
TRENDS/DISRUPTIONS IMPACT
MARKET DYNAMICS
MARKET ECOSYSTEM
MARKET SEGMENTS
MARKET REGION
COMPANY EVALUATION MATRIX
KEY MARKET PLAYERS
REPORT SCOPE
WHAT'S IN IT FOR YOU
DELIVERED CUSTOMIZATION
RECENT DEVELOPMENTS

METHODOLOGY

Need a Tailored Report?

Customize this report to your needs

Get 10% FREE Customization

Customize This Report

Fact checked

Cite this Research

Adjacent Markets

Request Bundle Reports

Personalize This Research

Triangulate with your Own Data
Get Data as per your Format and Definition
Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
Any level of Personalization

Request A Free Customisation

Let Us Help You

What are the Known and Unknown Adjacencies Impacting the Cardiac Monitoring & Rhythm Management Devices Market
What will your New Revenue Sources be?
Who will be your Top Customer; what will make them switch?
Defend your Market Share or Win Competitors
Get a Scorecard for Target Partners

Customized Workshop Request

TESTIMONIALS

JAYANT RAJPUROHIT

Director of Market Insights, Data and Analytics

SFI Health,

Leading Pharmaceutical Company

www.sfihealth.com/

We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.

BEATRIZ DE LA CALLE

Head of Commercial Analytics

Qualicaps,

Leading Pharmaceutical Company

www.qualicaps.com/

We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.

Bob Williams,

Senior Director Business Development & Innovation

Bracco Diagnostics Inc.,

Italian Multinational in life sciences sector and a World Leader in imaging diagnostics

imaging.bracco.com/us-en

We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.

Cody Coonradt,

Market Development and Strategy Manager

3M Health Information Systems,

Leader in Health care Coding, Payment & Analytics Solutions.

www.3m.com/3M/en_US/health-information-systems-us

The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.

Their customer first approach and high value engagement model, have given us great analysis and excellent value for money